Publications by authors named "Francesca Schieppati"

Claim this Profile
M
Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study.
Vincent R Lanting, Floris T M Bosch, Emily S L Martens, Pieter W Kamphuisen, Stefano Barco, Francesca Schieppati

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.
Raffaella Origa, Barbara Gianesin, Antonietta Zappu, Anna Rita Denotti, Mary Ann Di Giorgio, Francesca Schieppati

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.
Marina Marchetti, Patricia Gomez-Rosas, Laura Russo, Carmen Julia Tartari, Silvia Bolognini, Francesca Schieppati

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.
Patricia Gomez-Rosas, Magdolna Nagy, Henry M H Spronk, Laura Russo, Sara Gamba, Francesca Schieppati

J Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients.
Patricia Gomez-Rosas, Carmen Julia Tartari, Laura Russo, Silvia Bolognini, Chiara Ticozzi, Francesca Schieppati

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion strategies in hemoglobinopathies: what the latest update of Good Practices tells us in the era of new therapeutic advances.
Francesca Schieppati

Blood Transfus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms.
Sarah Kelliher, Sara Gamba, Luisa Weiss, Zhu Shen, Marina Marchetti, Francesca Schieppati

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19 thrombotic sequelae: The potential role of persistent platelet hyperactivity.
Francesca Schieppati

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
Vanja Zeremski, Ellen D McPhail, Thomas M Habermann, Francesca Schieppati, Niklas Gebauer

Hematol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
Francesca Schieppati, Laura Russo, Sara Gamba, Elisa Galimberti, Cinzia Giaccherini

Thromb Haemost· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms.
Sarah Kelliher, Sara Gamba, Luisa Weiss, Zhu Shen, Marina Marchetti, Francesca Schieppati

bioRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Patricia Gomez-Rosas, Cinzia Giaccherini, Laura Russo, Cristina Verzeroli, Sara Gamba, Francesca Schieppati

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
Cristina Verzeroli, Cinzia Giaccherini, Laura Russo, Silvia Bolognini, Sara Gamba, Francesca Schieppati

J Thromb Haemost· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction treatment in high-grade B-cell lymphoma with a concurrent and and/or rearrangement: a systematic review and meta-analysis.
Vanja Zeremski, Siegfried Kropf, Michael Koehler, Niklas Gebauer, Ellen D McPhail, Francesca Schieppati

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.
Cinzia Giaccherini, Cristina Verzeroli, Laura Russo, Sara Gamba, Carmen Julia Tartari, Francesca Schieppati

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.
Marina Marchetti, Patricia Gomez-Rosas, Laura Russo, Sara Gamba, Eleonora Sanga, Francesca Schieppati

Front Cardiovasc Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?
Francesca Schieppati, Anna Falanga

Hematology Am Soc Hematol Educ Program· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.
Marina Marchetti, Patricia Gomez-Rosas, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Francesca Schieppati

TH Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms.
Anna Falanga, Marina Marchetti, Francesca Schieppati

Hamostaseologie· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Erika Borlenghi, Chiara Cattaneo, Elisa Cerqui, Silvana Archetti, Diego Bertoli, Francesca Schieppati

Hematol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
Francesca Schieppati, Laura Russo, Marina Marchetti, Luca Barcella, Maurizio Cefis

Am J Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increase in copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.
Francesca Schieppati, Piera Balzarini, Simona Fisogni, Alessandro Re, Chiara Pagani

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: A Candidate Gene for Predisposition to "Blend Pedigrees"? A Case Report from the NEXT-Famly Clinical Trial.
Simona Bernardi, Mirko Farina, Camilla Zanaglio, Federica Cattina, Nicola Polverelli, Francesca Schieppati

Case Rep Hematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients.
Anna Falanga, Francesca Schieppati, Laura Russo

Cancer Treat Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
Mariella D'Adda, Mirko Farina, Francesca Schieppati, Erika Borlenghi, Chiara Bottelli

Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis